靶向三阴性乳腺癌中的PI3K/AKT信号通路。 - Suppr

Suppr

超能文献

Targeting PI3K/AKT pathway in triple-negative breast cancer.

作者信息

Delaloge Suzette, DeForceville Louise

机构信息

Department of Medical Oncology, Gustave Roussy, 94800 Villejuif, France.

出版信息

Lancet Oncol. 2017 Oct;18(10):1293-1294. doi: 10.1016/S1470-2045(17)30514-4. Epub 2017 Aug 8.

DOI:10.1016/S1470-2045(17)30514-4

PMID:28800863

Abstract

摘要

相似文献

Targeting PI3K/AKT pathway in triple-negative breast cancer.靶向三阴性乳腺癌中的PI3K/AKT信号通路。

Lancet Oncol. 2017 Oct;18(10):1293-1294. doi: 10.1016/S1470-2045(17)30514-4. Epub 2017 Aug 8.

[Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].三阴性乳腺癌细胞对磷脂酰肌醇3-激酶抑制剂耐药的分子机制

Zhonghua Zhong Liu Za Zhi. 2016 Aug;38(8):578-88. doi: 10.3760/cma.j.issn.0253-3766.2016.08.004.

Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.莪术根茎通过 PI3K/Akt/mTOR 通路抑制三阴性乳腺癌细胞的增殖、迁移、侵袭和转移。

J Ethnopharmacol. 2018 Jan 30;211:89-100. doi: 10.1016/j.jep.2017.09.033. Epub 2017 Sep 27.

Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells.培柏宁，一种生物碱，通过抑制 PI3K/Akt/mTOR 信号通路诱导人三阴性乳腺癌细胞发生 caspase 依赖性凋亡。

Apoptosis. 2014 Jul;19(7):1148-64. doi: 10.1007/s10495-014-0991-2.

Combination of SF1126 and gefitinib induces apoptosis of triple-negative breast cancer cells through the PI3K/AKT-mTOR pathway.SF1126与吉非替尼联合通过PI3K/AKT-mTOR途径诱导三阴性乳腺癌细胞凋亡。

Anticancer Drugs. 2015 Apr;26(4):422-7. doi: 10.1097/CAD.0000000000000202.

Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.抑制 PI3K/Akt/mTOR 可克服三阴性乳腺癌细胞系 HCC38 对顺铂的耐药性。

BMC Cancer. 2017 Nov 3;17(1):711. doi: 10.1186/s12885-017-3695-5.

PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?PI3K/AKT/mTOR通路抑制剂：乳腺癌治疗的理想联合伙伴？

Expert Rev Anticancer Ther. 2015 Jan;15(1):51-68. doi: 10.1586/14737140.2015.961429. Epub 2014 Oct 11.

Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.整合素β1、肌球蛋白轻链激酶和肌球蛋白IIA是转移性三阴性乳腺癌中MEK抑制后PI3K-AKT信号通路激活所必需的。

Oncotarget. 2016 Sep 27;7(39):63466-63487. doi: 10.18632/oncotarget.11525.

Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways.由于Wnt和PI3K/AKT信号通路的不同激活，三阴性乳腺癌细胞之间存在异质性。

Exp Cell Res. 2015 Nov 15;339(1):67-80. doi: 10.1016/j.yexcr.2015.10.006. Epub 2015 Oct 21.

Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway.从黄芪中提取的物质通过 PI3K/AKT/mTOR 信号通路抑制乳腺癌细胞增殖。

BMC Complement Altern Med. 2018 Mar 9;18(1):83. doi: 10.1186/s12906-018-2148-2.

引用本文的文献

Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research.癌症治疗中靶向I类-II类-III类磷脂酰肌醇-3-激酶：肿瘤生物学与临床前研究的最新进展

Cancers (Basel). 2023 Jan 27;15(3):784. doi: 10.3390/cancers15030784.

miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR/AKT signaling.miR-4461 通过调节 EGFR/AKT 信号通路抑制胆囊癌的进展。

Cell Cycle. 2022 Jun;21(11):1166-1177. doi: 10.1080/15384101.2022.2042775. Epub 2022 Feb 23.

The Discovery of New Drug-Target Interactions for Breast Cancer Treatment.用于乳腺癌治疗的新药靶标相互作用的发现。

Molecules. 2021 Dec 10;26(24):7474. doi: 10.3390/molecules26247474.

Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy.新型双重靶向溴结构域蛋白 4/酪蛋白激酶 2 抑制剂的发现可诱导三阴性乳腺癌治疗中的细胞凋亡和自噬相关细胞死亡。

J Med Chem. 2021 Dec 23;64(24):18025-18053. doi: 10.1021/acs.jmedchem.1c01382. Epub 2021 Dec 15.

He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study.和剂参湿汤作为2019年重症冠状病毒病辅助治疗的回顾性队列及潜在机制研究

Front Pharmacol. 2021 Jun 18;12:700498. doi: 10.3389/fphar.2021.700498. eCollection 2021.

Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer.低剂量PI3K抑制剂增强免疫监视促进乳腺癌的早期干预。

Am J Cancer Res. 2021 May 15;11(5):2005-2024. eCollection 2021.

Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component.胰腺癌细胞内在的 PI3Kα 活性加速转移并重塑巨噬细胞组成。

EMBO Mol Med. 2021 Jul 7;13(7):e13502. doi: 10.15252/emmm.202013502. Epub 2021 May 25.

The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway.十六烷基三甲基溴化铵通过 PI3K/AKT 信号通路对人骨肉瘤的抑制作用。

Int J Oncol. 2021 Jul;59(1). doi: 10.3892/ijo.2021.5222. Epub 2021 May 20.

Triple-negative breast cancer: A run-through of features, classification and current therapies.三阴性乳腺癌：特征、分类及当前治疗方法概述

Oncol Lett. 2021 Jul;22(1):512. doi: 10.3892/ol.2021.12773. Epub 2021 May 5.

GPRC5A Is a Negative Regulator of the Pro-Survival PI3K/Akt Signaling Pathway in Triple-Negative Breast Cancer.GPRC5A是三阴性乳腺癌中促生存PI3K/Akt信号通路的负调节因子。

Front Oncol. 2021 Feb 16;10:624493. doi: 10.3389/fonc.2020.624493. eCollection 2020.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验